Carvedilol
کارودیلول
❤️ Cardiovascular SystemNon-selective beta-blocker with alpha-1 blockade
Market / country: 🇺🇸 USA
Coreg (US)
🧮 Dose calculator
Heart failure · Regimen source: FDA Carvedilol · 2.1
- • If tolerated, increase to 6.25, 12.5 and 25 mg twice daily, each step ≥2 weeks. Max 50 mg twice daily in patients >85 kg with mild–moderate HF. With food. FDA Carvedilol · 2.1FDA Carvedilol · 2
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Bronchial asthma or related bronchospastic conditions (and other items in section 4). FDA Carvedilol · 4
Formulations
- 3.125 mg tablet — tablet 🇺🇸 USA FDA Carvedilol · 3
- 6.25 mg tablet — tablet 🇺🇸 USA FDA Carvedilol · 3
- 12.5 mg tablet — tablet 🇺🇸 USA FDA Carvedilol · 3
- 25 mg tablet — tablet 🇺🇸 USA FDA Carvedilol · 3
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Carvedilol · 8.1
“Risk Summary Available data regarding use of carvedilol in pregnant women are insufficient to determine whether there are drug-associated risks of adverse developmental outcomes.”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Carvedilol · 8.2
“Risk Summary There are no data on the presence of carvedilol in human milk, the effects on the breastfed infant, or the effects on milk production.”
- 👶 ChildrenSafety not established
Label: safety and effectiveness in children have not been established. FDA Carvedilol · 8.4
“Effectiveness of carvedilol tablets in patients younger than 18 years has not been established.”
- 👴 Older adultsNo specific problem stated
Label: no specific difference or dose adjustment stated for older adults. FDA Carvedilol · 8.5
“With the exception of dizziness in hypertensive subjects (incidence 8.8% in the elderly versus 6% in younger subjects), no overall differences in the safety or effectiveness (see Figure 2 and 4) were observed between the older subjects and younger subjects in each of these populations.”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)ANDA077614
- DailyMed (FDA label)FDA Carvedilol
- MedlinePlus (NIH)Carvedilol
- WHO ATC/DDDC07AG02
- Darooyab (Iran)Carvedilol
🇮🇷 Registered in Iran Darooyab · G-1586/Carvedilol
Dosage forms with Iranian generic codes, per Darooyab.
- 01924 · CARVEDILOL 12.5MG TAB · قرص کارودیلول ۱۲٫۵ میلیگرم
- 01925 · CARVEDILOL 25MG TAB · قرص کارودیلول ۲۵ میلیگرم
- 07448 · CARVEDILOL 3.125MG TAB · قرص کارودیلول ۳٫۱۲۵ میلیگرم
- 02475 · CARVEDILOL 6.25MG TAB · قرص کارودیلول ۶٫۲۵ میلیگرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Carvedilol · 3FDA Carvedilol · 2.1FDA Carvedilol · 2FDA Carvedilol · 2.2FDA Carvedilol · 2.3FDA Carvedilol · 8.4FDA Carvedilol · 4FDA Carvedilol · 8.1FDA Carvedilol · 8.2FDA Carvedilol · 8.5FDA Carvedilol · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-1586/Carvedilol
- Clinical review⚠ Unverified